Alpha Centric Advisors LLC Bristol Myers Squibb CO Transaction History

Alpha Centric Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $5,499 - $6,149	-95 Reduced 2.92%	3,153 $183,000
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $14,717 - $16,340	-231 Reduced 6.64%	3,248 $207,000
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $2,562 - $2,906	-39 Reduced 1.11%	3,479 $241,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $240,912 - $285,274	3,518 New	3,518 $253,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $1,560 - $922,080	-12,000 Closed	0 $0
Q4 2021 Feb 25, 2022	BUY	$53.63 - $62.52 $605,482 - $705,850	11,290 Added 1590.14%	12,000 $748,000
Q2 2020 Mar 11, 2022	BUY	$54.82 - $64.09 $38,922 - $45,503	710 New	710 $42,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.